Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease
NCT ID: NCT01638832
Last Updated: 2012-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
572 participants
INTERVENTIONAL
2012-06-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Transient Elastography and Controlled Attenuation Parameter using the FibroScan
* blood examination including biochemical markers The results of non-invasive liver steatosis and fibrosis measurement are compared with the results of coronary angiogram concerning the presence or absence of coronary artery disease.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus
NCT01997424
NASH and Coronary Disease
NCT03819283
Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.
NCT01985009
A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations
NCT03726827
Effect of Thyroid Disorders in Liver Diseases
NCT06071923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transient Elastography (FibroScan), Echosens, Paris, France
Controlled Attenuation Parameter (CAP), Echosens, Paris, France
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written consent
* Coronary angiogram planned
Exclusion Criteria
* Pregnancy or lactation
* Ascites
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johann Wolfgang Goethe University Hospital
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mireen Friedrich-Rust, MD
Role: PRINCIPAL_INVESTIGATOR
Klinikum der J. W. Goethe-Universität Frankfurt am Main
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinikum der J. W. Goethe-Universität
Frankfurt am Main, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JWGUHMED1-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.